Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin in diabetic adults hospitalized with COVID-19
IRCT20200420047147N2Phase 3Completed
- Sponsor
- Aja University of Medical Sciences
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of sitagliptin in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Aja University of Medical Sciences. Primary endpoints: fever, oxygen saturation and 1 more. Started Mar 2022; status: completed.
02
Drugs
sitagliptin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200420047147N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200420047147N2.